ResearchMoz

Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets

GBI Research
Published Date » 2014-05-14
No. Of Pages » 84
   
 GBI Research’s report: “Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets” discusses the market, competitive landscape, and trends for two facial aesthetics market segments: Botox and dermal fillers. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the dynamics of the market. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important merger and acquisition deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts....
Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9

2 Executive Summary 11
2.1 Facial Aesthetics Market Expected to Grow Rapidly during the Forecast Period 11
2.2 Allergan Dominates the Global Facial Aesthetics Market 12
2.3 US will Continue to be the Largest Market for Facial Aesthetics 13
2.4 Hyaluronic Acid Fillers the Fastest Growing Segment due to Greater Affordability and Good Safety Profiles 15
2.5 Global Facial Aesthetics Market has High Exposure to Economic Volatility 16

3 Introduction 18
3.1 GBI Research Report Guidance 18

4 Analyst Commentary 19

5 Global Facial Aesthetics Market: Device Overview 21
5.1 Facial Aesthetics 21
5.1.1 Dermal Fillers 21
5.1.2 Particle and Polymer Fillers 21
5.1.3 Botox 21

6 Global Facial Aesthetics Market: Market Characterization 22
6.1 Global Facial Aesthetics Market, Revenue, 2006–2020 22
6.2 Botox Market, Global, Key Company Shares, 2013 23
6.3 Dermal Fillers Market, Global, Key Company Shares, 2013 26
6.4 Facial Aesthetics Market, Key Trends 28
6.4.1 Topical Neurotoxins to Drive Future Growth of Botox Market 29
6.4.2 Companies Focus on Autologous Injectables for Sustained Future Growth 30
6.4.3 Survey Results Indicate Expanding Patient Demographics for Facial Injectables 31
6.5 Market Dynamics 32
6.5.1 Market Drivers 32
6.5.2 Market Restraints 37

7 Global Facial Aesthetics Market: Segment Analysis and Forecasts 39
7.1 Botox Market, Global, Revenue, 2006–2020 39
7.2 Dermal Fillers Market, Global, Revenue, 2006–2020 40

8 Global Facial Aesthetics Market: Country Analysis and Forecasts 43
8.1 Facial Aesthetics Market: Cross-country Analysis 43
8.2 Historic and Forecast Revenue and Volume, by Country 45
8.2.1 Facial Aesthetics Market, US, Revenue and Volume, 2006–2020 45
8.2.2 Facial Aesthetics Market, Japan, Revenue and Volume, 2006–2020 47
8.2.3 Facial Aesthetics Market, Germany, Revenue and Volume, 2006–2020 50
8.2.4 Facial Aesthetics Market, France, Revenue, 2006–2013 53
8.2.5 Facial Aesthetics Market, Korea, Revenue and Volume, 2006–2020 56
8.2.6 Facial Aesthetics Market, Spain, Revenue, Volume, 2006–2020 58
8.2.7 Facial Aesthetics Market, Italy, Revenue, Volume, 2006–2020 60
8.2.8 Facial Aesthetics Market, Colombia, Revenue, Volume, 2006–2020 62
8.2.9 Facial Aesthetics Market, China, Revenue, Volume, 2006–2020 64
8.2.10 Facial Aesthetics Market, Turkey, Revenue, Volume, 2006–2020 66
8.2.11 Facial Aesthetics Market, India, Revenue, 2006–2013 68
8.2.12 Facial Aesthetics Market, Brazil, Revenue, 2006–2020 70

9 Global Facial Aesthetics Market: Competitive Landscape 72
9.1 Comparison of Leading Botox Brands, 2014 72
9.2 Comparison of Leading Hyaluronic Acid-Based Fillers, 2014 74
9.3 Global Facial Aesthetics Market, Competitive Assessment 77
9.4 Company Profiles 78
9.4.1 Allergan 78
9.4.2 Merz Aesthetics 79
9.4.3 Galderma 79
9.4.4 Valeant Pharmaceuticals International 80
9.4.5 Mentor Worldwide 81
9.4.6 Anika Therapeutics 81
9.4.7 Anteis 82
9.4.8 Adoderm 83
9.4.9 Alcon Laboratories 83
9.4.10 BioPolymer 84
9.4.11 Contura International 84
9.4.12 LCA Pharmaceutical 85
9.4.13 Laboratories Orgév 85
9.4.14 Polymekon 86
9.4.15 Prollenium Medical Technologies 86
9.4.16 Teoxane 87
9.4.17 Zimmer 87
9.4.18 Suneva Medical 88
9.4.19 Revitacare 89
9.4.20 Medytox 89
9.4.21 HuGel 90

10 Global Facial Aesthetics Market: Product Pipeline Analysis 91
10.1 Facial Aesthetics Market: List of Pipeline Products 92
10.1.1 Dermal Fillers, List of Pipeline Products 92
10.1.2 Botox, List of Pipeline Products 93
10.2 Facial Aesthetics Market: Profiles of Key Pipeline Products 94
10.2.1 Aquamid 94
10.2.2 Autologous Globin Dermal Filler 94
10.2.3 BioDermal Filler 94
10.2.4 Collagen Scaffold – Aesthetic Procedures 95
10.2.5 Dermal Filler 95
10.2.6 Dermal Filler 96
10.2.7 Gold Nanoparticle Dermal Filler 96
10.2.8 Hyaluderm 97
10.2.9 Injectable Dermal Filler 97
10.2.10 Juvéderm Volbella 98
10.2.11 Juvéderm Volift 98
10.2.12 Juvéderm Voluma XC 99
10.2.13 Macdermol 18 99
10.2.14 Macdermol 21 100
10.2.15 Macdermol 24 100
10.2.16 Macdermol 30 101
10.2.17 Macdermol Bio Lift 101
10.2.18 Macdermol Bio Revitalization 102
10.2.19 Macdermol Body Contour 103
10.2.20 Macdermol Hydro 103
10.2.21 Macdermol Lips 104
10.2.22 MacDermol R 104
10.2.23 MacDermol S 105
10.2.24 Macdermol Scalp Stimulation 105
10.2.25 Macdermol Volume 106
10.2.26 Matridex 106
10.2.27 Matridur 107
10.2.28 Matrigel 107
10.2.29 Next Generation Elevess Dermal Filler 108
10.2.30 Puragen 108
10.2.31 Puragen Plus 109
10.2.32 Restylane Touch 109
10.2.33 Tenergel 110
10.2.34 Wrinkle Filler 110
10.2.35 RT-001 111
10.2.36 RT-002 111
10.2.37 ANT-1207 112
10.2.38 NT-201 112

11 Facial Aesthetics Market: Consolidation Landscape 113
11.1 Key Deals, 2014 113
11.1.1 Valeant’s Offer to Buy Allergan, 2014 113
11.1.2 Deal Rationale 113
11.2 Key Deals (2009–2013) 114
11.2.1 Merz’s Acquisition of Anteis, 2013 114
11.2.2 Valeant’s Acquisition of Medicis, 2012 114
11.2.3 Merz Completes Acquisition of BioForm Medical, 2010 114
11.2.4 Galderma’s Acquisition of Q-Med, 2010 114
11.2.5 Johnson & Johnson’s Acquisition of Mentor, 2009 115

12 Appendix 116
12.1 Definitions 116
12.1.1 Facial Aesthetics 116
12.2 Abbreviations 116
12.3 Bibliography 117
12.4 Research Methodology 118
12.4.1 Secondary Research 118
12.4.2 Primary Research 118
12.4.3 Models 119
12.4.4 Forecasts 119
12.4.5 Expert Panel 119
12.5 Contact Us 120
12.6 Disclaimer 120

List of Tables

Table 1: Facial Aesthetics Market, Global, Revenue Forecast ($bn), 2006–2020 22
Table 2: Facial Aesthetics Market, Botox, Global, Key Company Share (%), 2013 24
Table 3: Facial Aesthetics Market, Dermal Fillers, Global, Key Company Share (%), 2013 27
Table 4: Facial Aesthetics Market, US Real GDP ($ trillion), Facial Aesthetic Procedures (million), 2014 38
Table 5: Facial Aesthetics Market, Botox, Global, Revenue Forecast ($bn), 2006–2020 39
Table 6: Facial Aesthetics Market, Dermal Fillers, Global, Revenue ($m), 2006–2020 41
Table 7: Facial Aesthetics Market, Global, Cross-country Analysis, CAGR (%), 2006–2020 44
Table 8: Facial Aesthetics Market, US, Revenue ($bn) and Number of Procedures (million), 2006–2020 46
Table 9: Facial Aesthetics Market, Japan, Revenue ($m) and Number of Procedures (‘000), 2013–2020 50
Table 10: Facial Aesthetics Market, Germany, Revenue ($m) and Number of Procedures (‘000), 2013–2020 52
Table 11: Facial Aesthetics Market, France, Revenue ($m) and Number of Procedures (‘000), 2006–2020 55
Table 12: Facial Aesthetics Market, Korea, Revenue ($m) and Number of Procedures (‘000), 2006–2020 57
Table 13: Facial Aesthetics Market, Spain, Revenue ($m) and Number of Procedures (‘000), 2006–2020 59
Table 14: Facial Aesthetics Market, Italy, Revenue ($m) and Number of Procedures (‘000), 2013–2020 61
Table 15: Facial Aesthetics Market, Colombia, Revenue ($m) and Number of Procedures (‘000), 2006–2020 63
Table 16: Facial Aesthetics Market, China, Revenue ($m) and Number of Procedures (‘000), 2013–2020 65
Table 17: Facial Aesthetics Market, Turkey, Revenue ($m) and Number of Procedures (‘000), 2013–2020 67
Table 18: Facial Aesthetics Market, India, Revenue ($m) and Number of Procedures (‘000), 2006–2020 69
Table 19: Facial Aesthetics Market, Brazil, Revenue ($m) and Number of Procedures (‘000), 2006–2020 71
Table 20: Facial Aesthetics Market, Allergan, Key Marketed Products, 2014 79
Table 21: Facial Aesthetics Market, Merz Aesthetics, Key Marketed Products, 2014 79
Table 22: Facial Aesthetics Market, Galderma, Key Marketed Products, 2014 80
Table 23: Facial Aesthetics Market, Valeant Pharmaceuticals International, Key Marketed Products, 2013 81
Table 24: Facial Aesthetics Market, Mentor Worldwide LLC, Key Marketed Products, 2013 81
Table 25: Facial Aesthetics Market, Anika Therapeutics, Key Marketed Products, 2013 82
Table 26: Facial Aesthetics Market, Anteis, Key Marketed Products, 2013 83
Table 27: Facial Aesthetics Market, Adoderm, Key Marketed Products, 2013 83
Table 28: Facial Aesthetics Market, Alcon Laboratories, Key Marketed Products, 2013 84
Table 29: Facial Aesthetics Market, BioPolymer, Key Marketed Products, 2013 84
Table 30: Facial Aesthetics Market, Contura International, Key Marketed Products, 2013 85
Table 31: Facial Aesthetics Market, LCA Pharmaceutical, Key Marketed Products, 2013 85
Table 32: Facial Aesthetics Market, Laboratories Orgév, Key Marketed Products, 2014 86
Table 33: Facial Aesthetics Market, Polymekon, Key Marketed Products, 2014 86
Table 34: Facial Aesthetics Market, Prollenium Medical Technologies, Key Marketed Products, 2014 87
Table 35: Facial Aesthetics Market, Teoxane, Key Marketed Products, 2014 87
Table 36: Facial Aesthetics Market, Zimmer, Key Marketed Products, 2014 88
Table 37: Facial Aesthetics Market, Suneva Medical, Key Marketed Products, 2014 89
Table 38: Facial Aesthetics Market, Revitacare, Key Marketed Products, 2014 89
Table 39: Facial Aesthetics Market, Medytox, Key Marketed Products, 2014 90
Table 40: Facial Aesthetics Market, HuGel, Key Marketed Products, 2014 90
Table 41: Facial Aesthetics Market, Dermal Fillers, Global, List of Pipeline Products, 2014 92
Table 42: Facial Aesthetics Market, Botox, Global, List of Pipeline Products, 2014 93
Table 43: Facial Aesthetics Market, Aquamid, Product Status, 2014 94
Table 44: Facial Aesthetics Market, Autologous Globin Dermal Filler, Product Status, 2014 94
Table 45: Facial Aesthetics Market, BioDermal Filler, Product Status, 2014 95
Table 46: Facial Aesthetics Market, Collagen Scaffold Aesthetic Procedures, Product Status, 2013 95
Table 47: Facial Aesthetics Market, Dermal Filler, Product Status, 2013 96
Table 48: Facial Aesthetics Market, Dermal Filler, Product Status, 2013 96
Table 49:  Facial Aesthetics Market, Gold Nanoparticle Dermal Filler, Product Status, 2013 97
Table 50: Facial Aesthetics Market, Hyaluderm, Product Status, 2013 97
Table 51: Facial Aesthetics Market, Injectable Dermal Filler, Product Status, 2013 98
Table 52:  Facial Aesthetics Market, Juvéderm Volbella, Product Status, 2014 98
Table 53: Facial Aesthetics Market, Juvéderm Volift, Product Status, 2014 99
Table 54: Facial Aesthetics Market, Juvéderm Voluma XC, Product Status, 2014 99
Table 55:  Facial Aesthetics Market, Macdermol 18, Product Status, 2013 100
Table 56:  Facial Aesthetics Market, Macdermol 21, Product Status, 2014 100
Table 57:  Facial Aesthetics Market, Macdermol 24, Product Status, 2013 101
Table 58: Facial Aesthetics Market, Macdermol 30, Product Status, 2013 101
Table 59: Facial Aesthetics Market, Macdermol Bio Lift, Product Status, 2014 102
Table 60: Facial Aesthetics Market, Macdermol Bio Revitalization, Product Status, 2014 103
Table 61:  Facial Aesthetics Market, Macdermol Body Contour, Product Status, 2014 103
Table 62: Facial Aesthetics Market, Macdermol Hydro, Product Status, 2014 104
Table 63: Facial Aesthetics Market, Macdermol Lips, Product Status, 2013 104
Table 64:  Facial Aesthetics Market, MacDermol R, Product Status, 2014 105
Table 65:  Facial Aesthetics Market, MacDermol S, Product Status, 2014 105
Table 66: Facial Aesthetics Market, Macdermol Scalp Stimulation, Product Status, 2013 106
Table 67: Facial Aesthetics Market, Macdermol Volume, Product Status, 2014 106
Table 68:  Facial Aesthetics Market, Matridex, Product Status, 2014 107
Table 69:  Facial Aesthetics Market, Matridur, Product Status, 2014 107
Table 70: Facial Aesthetics Market, Matrigel, Product Status, 2014 108
Table 71: Facial Aesthetics Market, Next Generation Elevess Dermal Filler, Product Status, 2014 108
Table 72:  Facial Aesthetics Market, Puragen, Product Status, 2014 109
Table 73:  Facial Aesthetics Market, Puragen Plus, Product Status, 2014 109
Table 74: Facial Aesthetics Market, Restylane Touch, Product Status, 2014 110
Table 75: Facial Aesthetics Market, Tenergel, Product Status, 2014 110
Table 76: Facial Aesthetics Market, Wrinkle Filler, Product Status, 2014 111
Table 77:  Facial Aesthetics Market, RT-001, Product Status, 2014 111
Table 78: Facial Aesthetics Market, RT-002, Product Status, 2014 112
Table 79:  Facial Aesthetics Market, ANT-1207, Product Status, 2014 112
Table 80: Facial Aesthetics Market, NT-201, Product Status, 2014 113

List of Figures

Figure 1: Facial Aesthetics Market, Global, Revenue ($bn), 2013–2020 11
Figure 2: Facial Aesthetics Market, Global, Key Company Share (%), 2013 12
Figure 3: Facial Aesthetics Market, Global, Revenue Contribution by Region (%), 2013–2020 13
Figure 4:  Facial Aesthetics Market, Hyaluronic Acid-Based Fillers Market, Global, Revenue ($bn), 2013–2020 15
Figure 5: Facial Aesthetics Market, US Real GDP ($ trillion), Facial Aesthetic Procedures (million), 2007–2013 16
Figure 6: Facial Aesthetics Market, Device Overview 21
Figure 7: Facial Aesthetics Market, Global, Revenue ($bn), 2006–2020 22
Figure 8: Facial Aesthetics Market, Botox, Global, Key Company Share (%), 2013 24
Figure 9: Facial Aesthetics Market, Botox, US, Botox Cosmetic Price Trend, 1997–2009 25
Figure 10: Facial Aesthetics Market, Dermal Fillers, Global, Key Company Share (%), 2013 27
Figure 11: Facial Aesthetics Market, Market Trends 29
Figure 12: Facial Aesthetics Market, Market Dynamics 32
Figure 13: Facial Aesthetics Market, National Average Physician Fee, US, 2013 34
Figure 14: Facial Aesthetics Market, Studies Indicating Advantages of Dermal Fillers with Lidocaine, 2014 36
Figure 15: Facial Aesthetics Market, Botox, Global, Revenue Forecast ($bn), 2006–2020 39
Figure 16: Facial Aesthetics Market, Dermal Fillers, Global, Revenue Forecast ($bn), 2006–2020 41
Figure 17: Facial Aesthetics Market, Global, Cross-country Analysis, CAGR (%), 2006–2020 43
Figure 18: Facial Aesthetics Market, US, Cross-segment Analysis, CAGR (%), 2006–2020 45
Figure 19: Facial Aesthetics Market, US, Revenue ($bn) and Number of Procedures (million), 2006–2020 46
Figure 20: Facial Aesthetics Market, Japan, Cross-segment Analysis, CAGR (%), 2006–2020 48
Figure 21: Facial Aesthetics Market, Japan, Revenue and Number of Procedures (‘000), 2006–2020 49
Figure 22: Facial Aesthetics Market, Germany, Cross-segment Analysis, CAGR (%), 2006–2020 51
Figure 23: Facial Aesthetics Market, Germany, Revenue ($m) and Number of Procedures (‘000), 2006–2020 52
Figure 24: Facial Aesthetics Market, France, Cross-segment Analysis, CAGR (%), 2006–2020 54
Figure 25: Facial Aesthetics Market, France, Revenue ($m) and Number of Procedures (‘000), 2006–2020 55
Figure 26: Facial Aesthetics Market, Korea, Cross-segment Analysis, CAGR (%), 2006–2020 56
Figure 27: Facial Aesthetics Market, Korea, Revenue ($m) and Number of Procedures (‘000), 2006–2020 57
Figure 28: Facial Aesthetics Market, Spain, Cross-segment Analysis, CAGR (%), 2006–2020 58
Figure 29: Facial Aesthetics Market, Spain, Revenue ($m) and Number of Procedures (‘000), 2006–2020 59
Figure 30: Facial Aesthetics Market, Italy, Cross-segment Analysis, CAGR (%), 2006–2020 60
Figure 31: Facial Aesthetics Market, Italy, Revenue ($m) and Number of Procedures (‘000), 2006–2020 61
Figure 32: Facial Aesthetics Market, Colombia, Cross-segment Analysis, CAGR (%), 2006–2020 62
Figure 33: Facial Aesthetics Market, Colombia, Revenue ($m) and Number of Procedures (‘000), 2006–2020 63
Figure 34: Facial Aesthetics Market, China, Cross-segment Analysis, CAGR (%), 2006–2020 64
Figure 35: Facial Aesthetics Market, China, Revenue ($m) and Number of Procedures (‘000), 2006–2020 65
Figure 36: Facial Aesthetics Market, Turkey, Cross-segment Analysis, CAGR (%), 2006–2020 66
Figure 37: Facial Aesthetics Market, Turkey, Revenue ($m) and Number of Procedures (‘000), 2006–2020 67
Figure 38: Facial Aesthetics Market, India, Cross-segment Analysis, CAGR (%), 2006–2020 68
Figure 39: Facial Aesthetics Market, India, Revenue ($m) and Number of Procedures (‘000), 2006–2020 69
Figure 40: Facial Aesthetics Market, Brazil, Cross-segment Analysis, CAGR (%), 2006–2020 70
Figure 41: Facial Aesthetics Market, Brazil, Revenue ($m) and Number of Procedures (‘000), 2006–2020 71
Figure 42: Facial Aesthetics Market, Comparison of Leading Botox Brands, 2014 72
Figure 43: Facial Aesthetics Market, Comparison of Leading Dermal Fillers, 2014 74
Figure 44: Facial Aesthetics Market, Global, Competitive Assessment, 2014 77
Figure 45: Facial Aesthetics Market, Pipeline Products Summary, 2014 91

Upcoming Reports:

Self-Administration Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
The drugs that are taken by the patients on their own are known as self administration drugs. These drugs are administered in the body through implantable and non implantable infusion pumps which have an opening that comes in contact with the skin surface for injecting drugs. In addition, oral, over-the-counter and topical prescription drugs are also considered to be self administered drugs.  Self administered drugs include Actimmune, Afinitor, Apokyn, Enbrel, Cetrotide, Caprelsa, Cetrotide, Bosulif, Bravelle, Betaseron,Zytiga, Zorbtive, Zolinza, Xgeva, Zavesca, Xeloda,...
Neurostimulation Market - Advanced Technologies, Global Market and Industry Analysis, Size, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Driven by rising health awareness and continuous disruptive innovations made in the field of medical and biological technologies, the global market for neurostimulation is expected to reach a market size valued at USD 7.3 billion in year 2018. The market is expected to grow at a healthy CAGR of 8.2% from 2012 – 2018. It was estimated at USD 4.2 billion in 2011. Medical devices manufacturing companies and their technological affiliates or subsidiaries are continuously working on developing novel devices and technologies which can enhance the efficacy of existing...
Blood Pressure Monitoring & Measurement Instruments Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
The global market for blood pressure monitoring and measurement equipment is forecasted to reach $2.2 billion by the year 2015 driven by growing elderly population suffering from blood pressure problems, increasing consumer awareness about regular health check-ups, technological developments in monitoring systems, and increasing stress on healthcare industry in developing nations. Attractive features of blood pressure measuring instruments and convenience in using these devices is also fueling the market growth. Ambulatory monitoring is emerging as an important tool for diagnosing...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

A Health Tech Incubator Started by GE Healthcare
Oct 30, 2014  
For the very first time, a health tech start up campus has been established by GE Healthcare at its headquarters at Helsinki, Finland. This area already has about twenty such healthcare start ups that are working on cloud services, wireless technologies, apps, and sensors that aim at improving healthcare. The main rationale behind such a step is providing opportunities for further...
Net Earnings of DuPont Increases 52% despite Agricultural Turmoil
Oct 29, 2014  
DuPont - The Wilmington, Del-based leading chemical company faced decline of three percent sales to $7.5 billion in the quarter ending of September 30. The company’s third-quarter earnings were increased by 52 percent to $433 million albeit the slow global growth and agricultural downside.   The company witnessed the biggest drags from chemical sales with eight percent...
Appeal for Sanitization in Construction Industry through Government Regulations: CIOB Ghana
Oct 29, 2014  
Rockson Dogbegah - The Chairman of the Chartered Institute of Building Ghana commented that the construction industry needs a thorough cleaning up and assurance of proper growth. Mr. Dogbegah also said that a few factors are extremely important for a proper development in the construction industry. These include keen adherence to standards, supreme sense of professionalism, and sheer pursuance...
Facebook Hints of Rise in Expenses in 2015, Shares Drop
Oct 29, 2014  
Facebook has announced on Tuesday that it is prepping for a dramatic rise in spending in the year 2015. This warning has come combined with a projected slowdown in the company’s revenues after revenues were analyzed at the end of the third quarter of the year. The plans of such hefty spending in the next financial year by the company are indicative of stress in the investor...
Samsung Records Poorest Profits in Q3 2014
Oct 29, 2014  
In the quarter ending September 2014, Samsung Electronics Co. Ltd registered the smallest earnings ever in two years. The drop in earnings can be easily attributed to heavy competition from new Chinese devices and the Apple phones. The net income stood at US$4 billion for the South Korea-based company. Apple has been Samsung’s strongest contender ever since the latter entered the...